Elucidating mechanisms of HIV-1 mucosal transmission
Elucidating mechanisms of HIV-1 mucosal transmission
批准号:
9892706
负责人:
JOHN Christopher KAPPES
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-01 至 2023-12-31
关键词:
AIDS preventionAIDS/HIV problemAddressAffectApplications GrantsBiologyCD4 Positive T LymphocytesCellsCervicalCharacteristicsColorCommunicable DiseasesComplementConfocal MicroscopyDataDoseExhibitsExposure toFemaleFrequenciesHIVHIV-1HeterosexualsHumanHuman ResourcesImageIn SituIncidenceIndividualInfectionInvestigationMilitary PersonnelModalityModelingMucous MembranePathway interactionsPharmaceutical PreparationsPhysiologicalPopulationPredispositionPreventionPrevention strategyProcessPublic Health Applications ResearchPublishingReadinessRecording of previous eventsReporterResearchRiskRoleSIVServicesT-LymphocyteTimeTissuesTropismValidationVeteransVirusVirus ReplicationWomanWorkanalytical methodinnovationmacrophagemenmonocytenonhuman primatepandemic diseasepreventpublic health relevancereproductive tractspatial relationshipspatiotemporaltherapy developmenttransmission processviral transmissionvirologyvirus host interaction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
HIV/AIDS has spread relentlessly since it was first identified in 1983, causing one of the most devastating
pandemics in human history. Historical accounts of infectious diseases show that they can have a major
impact on U.S. Armed Forces. With 34 million individuals infected worldwide, HIV-1 poses a significant and
persistent threat to force readiness and the stability of many nation-states. The incidence of HIV/AIDS infection
among U.S. service personnel is significant and the risk of exposure to HIV-1 by heterosexual intercourse
among veterans and service personnel is much greater. Heterosexual HIV-1 transmission from men to women
accounts for the majority of new infections worldwide, and notably, women are entering into military service at
an increasing rate. The discovery of effective prevention modalities for women is hindered by a lack of basic
information about early virus-host interactions in the female genital tract mucosa that underlie the acquisition of
HIV-1 infection. Non-human primate (NHP) models of HIV/SIV transmission indicate that macrophages and
predominantly CD4 T cells become infected within the first few days after high-dose intravaginal challenge.
The observation of early CD4 T cell infection seemed consistent with subsequent published work indicating
transmitted/founder (TF) viruses generally exhibit low to moderate tropism for monocyte-derived macrophages
(MDM). However, recent published and unpublished data (Preliminary Studies) would argue that this central
question regarding HIV-1 transmission biology, and the role of macrophages in particular, warrants additional
investigation. Our central hypothesis is that cervical macrophages are required to drive HIV-1 replication and
spread in the cervical mucosa. Our corollary hypothesis, though beyond the immediate scope of this
application, is that cervical macrophages (cMφs) are required for expansion and spread of HIV-1 infection
beyond initial foci of infected CD4 T cell in the mucosa, and thus represent an underlying determinant of
mucosal HIV-1 heterosexual transmission in women. To interrogate this central hypothesis, we propose the
following specific aims: (1) To characterize the dynamics of HIV-1 infection and replication in human cervical
explant tissue; (2) To determine the spatiotemporal relationships between uninfected and HIV-1 infected cMφs
and CD4 T lymphocytes in cervical tissue in situ; and (3) To identify cellular determinants of cMφs
susceptibility to HIV-1 infection. Our research promise to elucidate critical virus-host interactions that underlie
the establishment of HIV-1 infection in the female mucosal genital tract. Validation of our central hypothesis
would impart a paradigm shift in the field, and implicate cMφs as a viable early target for the discovery of new
HIV/AIDS prevention strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The effects of masculinizing gender-affirming hormone therapy for transgender men on susceptibility to HIV-1 infection modelled ex vivo in cervical mucosal tissue
-
批准号:10748946
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2023
-
负责人:JOHN Christopher KAPPES
-
依托单位:
Elucidating mechanisms of HIV-1 mucosal transmission
-
批准号:10553626
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:JOHN Christopher KAPPES
-
依托单位:
Elucidating mechanisms of HIV-1 mucosal transmission
-
批准号:10428455
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:JOHN Christopher KAPPES
-
依托单位:
Analysis of human uterine mucosal cells as targets of HIV-1 infection
-
批准号:8925576
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:JOHN Christopher KAPPES
-
依托单位:
Virology
-
批准号:7685030
-
项目类别:
-
资助金额:$18.6万
-
财政年份:2009
-
负责人:JOHN Christopher KAPPES
-
依托单位:
Virology
-
批准号:7697009
-
项目类别:
-
资助金额:$10.2万
-
财政年份:2008
-
负责人:JOHN Christopher KAPPES
-
依托单位:
Single cycle reporter assay for quantifying HIV-1 Nab
-
批准号:6694007
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2003
-
负责人:JOHN Christopher KAPPES
-
依托单位:
CORE--CENTRAL VIRUS CULTURE
-
批准号:6299622
-
项目类别:
-
资助金额:$14.28万
-
财政年份:2000
-
负责人:JOHN Christopher KAPPES
-
依托单位:
ANALYSIS OF INTEGRASE IN REVERSE TRANSCRIPTION
-
批准号:6511302
-
项目类别:
-
资助金额:$25.11万
-
财政年份:2000
-
负责人:JOHN Christopher KAPPES
-
依托单位:
ANALYSIS OF INTEGRASE IN REVERSE TRANSCRIPTION
-
批准号:6374532
-
项目类别:
-
资助金额:$25.11万
-
财政年份:2000
-
负责人:JOHN Christopher KAPPES
-
依托单位:
ANALYSIS OF INTEGRASE IN REVERSE TRANSCRIPTION
-
批准号:6632295
-
项目类别:
-
资助金额:$25.11万
-
财政年份:2000
-
负责人:JOHN Christopher KAPPES
-
依托单位:
ANALYSIS OF INTEGRASE IN REVERSE TRANSCRIPTION
-
批准号:6147643
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2000
-
负责人:JOHN Christopher KAPPES
-
依托单位:
CORE--CENTRAL VIRUS CULTURE
-
批准号:6099415
-
项目类别:
-
资助金额:$14.28万
-
财政年份:1999
-
负责人:JOHN Christopher KAPPES
-
依托单位:
VIRUS ISOLATE-BASED HIV-1 RESISTANCE ASSAY
-
批准号:6017571
-
项目类别:
-
资助金额:$19.18万
-
财政年份:1999
-
负责人:JOHN Christopher KAPPES
-
依托单位:
CORE--CENTRAL VIRUS CULTURE
-
批准号:6268006
-
项目类别:
-
资助金额:$13.86万
-
财政年份:1998
-
负责人:JOHN Christopher KAPPES
-
依托单位:
TRANSCOMPLEMENTATION SYSTEM TO STUDY PROVIRUS SYNTHESIS
-
批准号:2700725
-
项目类别:
-
资助金额:$24.52万
-
财政年份:1997
-
负责人:JOHN Christopher KAPPES
-
依托单位:
TRANSCOMPLEMENTATION SYSTEM TO STUDY PROVIRUS SYNTHESIS
-
批准号:2895834
-
项目类别:
-
资助金额:$22.01万
-
财政年份:1997
-
负责人:JOHN Christopher KAPPES
-
依托单位:
TRANSCOMPLEMENTATION SYSTEM TO STUDY PROVIRUS SYNTHESIS
-
批准号:2428979
-
项目类别:
-
资助金额:$20.75万
-
财政年份:1997
-
负责人:JOHN Christopher KAPPES
-
依托单位:
TRANSCOMPLEMENTATION SYSTEM TO STUDY PROVIRUS SYNTHESIS
-
批准号:6172874
-
项目类别:
-
资助金额:$22.67万
-
财政年份:1997
-
负责人:JOHN Christopher KAPPES
-
依托单位:
CORE--CENTRAL VIRUS CORE
-
批准号:6234922
-
项目类别:
-
资助金额:$13.4万
-
财政年份:1997
-
负责人:JOHN Christopher KAPPES
-
依托单位: